Two Sigma Investments
AMBI

Two Sigma Investments’s Ambit Biosciences Corp AMBI Stock Holding History

Two Sigma Investments’s Portfolio AMBI Stock Details AMBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-21,673
Closed -$150K – 2364
2014
Q2 		$150K Buy
21,673
+4,573
+27% +$32.1K ﹤0.01% 2017
2014
Q1 		$156K Buy
+17,100
New +$181K ﹤0.01% 1843

Other funds holding AMBI

FCMI
Foresite Capital Management I Larkspur, California $21.4M AUM 80.48% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Two Sigma Investments's AMBI Position: Q3 2014 in Review

Two Sigma Investments sold out of Ambit Biosciences Corp (AMBI) in Q3 2014, closing a stake of 21,673 shares — an estimated $150K sold.

Two Sigma Investments first reported a position in AMBI in Q1 2014 and held it in 2 quarters. The position peaked at $156K in Q1 2014. 49 funds tracked by Wall St. Rank hold AMBI as of Q3 2014.

  • Two Sigma Investments reported no remaining Ambit Biosciences Corp position as of Q3 2014 after selling out during the quarter.
  • Two Sigma Investments sold 21,673 Ambit Biosciences Corp shares in Q3 2014, an estimated $150K.
  • Two Sigma Investments first reported a position in Ambit Biosciences Corp in Q1 2014 and held it in 2 quarters.
  • Two Sigma Investments's Ambit Biosciences Corp position peaked at $156K in Q1 2014.
  • 49 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q3 2014.

Based on Two Sigma Investments's 13F filing for Q3 2014, filed 14 Nov 2014.